Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-2197
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

HMGB1 Promotes Myeloid-Derived Suppressor Cells and Renal Cell Carcinoma Immune Escape

Oncotarget
Oncology
2017English

672 Pramlintide Produces Immunomodulatory Effects on Myeloid-Derived Suppressor Cells and T-Cells in Squamous Cell Carcinoma In-Vivo

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Myeloid-Derived Suppressor Cells in Transplantation: The Dawn of Cell Therapy

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

Myeloid-Derived Suppressor Cells in Autoimmune Diseases

Inflammation and Regeneration
AllergyImmunology
2014English

Myeloid-Derived Suppressor Cells and Myeloid Regulatory Cells in Cancer and Autoimmune Disorders

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

Targeting Myeloid-Derived Suppressor Cells in the Treatment of Hepatocellular Carcinoma: Current State and Future Perspectives

Journal of Hepatocellular Carcinoma
2019English

Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications

Seminars in Oncology
OncologyHematology
2014English

Myeloid Derived Suppressor Cells: Subsets, Expansion, and Role in Cancer Progression

2012English

Regulation of Accumulation and Function of Myeloid Derived Suppressor Cells in Different Murine Models of Hepatocellular Carcinoma

Journal of Hepatology
Hepatology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy